210 related articles for article (PubMed ID: 1638001)
1. [The clinical relevance of anti-CEA immunoscintigraphy with the 99mTc-labelled monoclonal antibody BW 431/26. A critical assessment after 119 studies].
Hach A; Wittig B; Piepenburg R; Steinert H; Lahmann C; Dippold W; Hahn K
Rofo; 1992 Jul; 157(1):3-10. PubMed ID: 1638001
[TBL] [Abstract][Full Text] [Related]
2. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma.
Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM
Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of 99mTc-anti-CEA immunoscintigraphy in patients with liver metastases from colorectal carcinoma.
Bock E; Becker W; Scheele J; Wolf F
Nuklearmedizin; 1992 Jun; 31(3):80-3. PubMed ID: 1641359
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoscintigraphy of colorectal carcinomas with 99mTc-labelled antibodies.
Artiko V; Petrović M; Sobić-Saranović D; Antić A; Koljević-Marković A; Krajnović-Jaksić E; Saranović D; Petrović N; Stojković M; Durutović D; Zuvela M; Radovanović-Bobić A; Galun D; Petrasinović Z; Pavlović S; Krivokapić Z; Obradović V
Hepatogastroenterology; 2011; 58(106):347-51. PubMed ID: 21661394
[TBL] [Abstract][Full Text] [Related]
5. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.
Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O
J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784
[TBL] [Abstract][Full Text] [Related]
6. Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
Poshyachinda M; Chaiwatanarat T; Saesow N; Thitathan S; Voravud N
Eur J Nucl Med; 1996 Jun; 23(6):624-30. PubMed ID: 8662095
[TBL] [Abstract][Full Text] [Related]
7. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
[TBL] [Abstract][Full Text] [Related]
8. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA.
Hertel A; Baum RP; Lorenz M; Baew-Christow T; Encke A; Hör G
Br J Cancer Suppl; 1990 Jul; 10():34-6. PubMed ID: 2166552
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy and tumor-targeting kinetics of complete versus fragmented 99mTc-labeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison.
Behr TM; Becker WS; Klein MW; Bair HJ; Scheele JR; Wolf FG
Cancer Res; 1995 Dec; 55(23 Suppl):5786s-5793s. PubMed ID: 7493347
[TBL] [Abstract][Full Text] [Related]
10. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up.
Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z
Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoscintigraphy of colorectal carcinoma with a 99Tcm-labelled anti-CEA monoclonal antibody (BW 431/26).
Muxí A; Solá M; Bassa P; Pons F; García A; Moragas M; Lomeña F; Herranz R; Fernández R; Trias M
Nucl Med Commun; 1992 Apr; 13(4):261-70. PubMed ID: 1589179
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-anti-CEA radioimmunoscintigraphy of lung adenocarcinoma.
Leitha T; Walter R; Schlick W; Dudczak R
Chest; 1991 Jan; 99(1):14-9. PubMed ID: 1984945
[TBL] [Abstract][Full Text] [Related]
13. [Immunogammagraphy with anti-CEA and anti-TAG-72 monoclonal antibodies in the diagnosis of colorectal carcinoma].
Muxí Pradas MA; Pons Pons F; Huguet Planella M; Novell Capilla F; García-Romero RH; Trias Folch M
Med Clin (Barc); 1996 Nov; 107(16):601-7. PubMed ID: 9064391
[TBL] [Abstract][Full Text] [Related]
14. [Clinical relevance of immunoscintigraphy with 99mTc-labelled anti-CEA antigen-binding fragments in the follow-up of patients with colorectal carcinoma. Assessment of surgical resectability with a combination of conventional imaging methods].
Behr TM; Goldenberg DM; Scheele JR; Wolf FG; Becker W
Dtsch Med Wochenschr; 1997 Apr; 122(15):463-70. PubMed ID: 9147937
[TBL] [Abstract][Full Text] [Related]
15. [The value of CEA immunoscintigraphy for diagnosis of colorectal cancer and its metastases: results of a prospective study].
Imdahl A; Bräutigam P; Hauenstein KH; Eggstein S; Waninger J; Farthmann EH
Zentralbl Chir; 1994; 119(1):17-22. PubMed ID: 8147155
[TBL] [Abstract][Full Text] [Related]
16. [Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results].
Oliva J; Pimentel G; Peralta R; Borrón M; Ortiz R; Gutiérrez J; Guerra J; Quesada W; Dopico R; Casanova F; Baum RP
Rev Esp Med Nucl; 1999; 18(1):5-15. PubMed ID: 10074212
[TBL] [Abstract][Full Text] [Related]
17. CEA-immunoscintigraphy with 99m-technetium correlates with tumour cell differentiation in colorectal cancer.
Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1993; 29A(9):1327-9. PubMed ID: 8343279
[TBL] [Abstract][Full Text] [Related]
18. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases].
Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H
Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409
[TBL] [Abstract][Full Text] [Related]
19. [Radioimmunoscintigraphy of colorectal tumors with 99m-Tc marked CEA antibodies. Indications and clinical value].
Barzen G; Martini I; Schulz W; Löhde E; Böse-Landgraf J; Richter W; Langer M; Felix R
Med Klin (Munich); 1992 Aug; 87(8):395-402. PubMed ID: 1406470
[TBL] [Abstract][Full Text] [Related]
20. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
